DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Reynolds PM, Van Matre ET, Wright GC. et al; Colorado Pulmonary Outcomes Research Group (CPOR).
Evaluation of prophylactic heparin dosage strategies and risk factors for venous thromboembolism in the critically ill patient.
Pharmacotherapy 2019;
39 (03) 232-241
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.